The results highlight the importance of supporting older adults so that their decision whether to have surgery isn't based on financial factors, the authors say.
GSK has applied for expanded RSV vaccine use in adults ages 50 to 59 who have underlying health conditions.
In a preliminary flu season severity assessment, the CDC said the season has been moderate.
Most errors didn't result in an adverse event, and the few that did were recorded as nonserious.
Signs are encouraging, though activity sometimes rises again after the holiday period.
Some downward trends might reflect changes in holiday-related health seeking behaviors.
Though COVID wastewater and test positivity are higher than last year at this time, medical encounters are trending lower.
Flu and COVID indicators continued upward trends, with different regions reporting the most intensive activity.
Nirsevimab was 83.2% effective in preventing hospitalization for RSV-associated lower respiratory tract infections.
Emergency department visits for COVID were highest in infants and older adults.